(Q39258568)

English

Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

inflammatory bowel diseases

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

Brian P Bosworth

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Himanshu Dev Verma

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ellen Janice Scherl

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Vinita Elizabeth Jacob

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Journal of Digestive Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

379-383

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955431%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Drug-induced lupus due to anti-tumor necrosis factor alpha agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Accumulation of plasma nucleosomes upon treatment with anti-tumour necrosis factor-alpha antibodies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Autoimmune Diseases Induced by TNF-Targeted Therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-2980.2011.00522.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39258568&oldid=1635466653"